Table 1 Baseline characteristics of the study population
Patients, N = 26 | |
|---|---|
Age, years | 69.8 ± 2.3 |
Men, n (%) | 20 (77%) |
Ischemic etiology, n (%) | 12 (46%) |
NYHA class III, n (%) | 26 (100%) |
SBP (mmHg) | 126.8 ± 3.1 |
DBP (mmHg) | 77.5 ± 2.1 |
Creatinine (mg/dl) | 1.1 ± 0.1 |
eGFR (ml/min/1.73m2) | 44.3 ± 4.1 |
Na+ (mEq/L) | 139.9 ± 0.5 |
K+ (mEq/L) | 4.4 ± 0.1 |
Smoking history, n (%) | 13 (50%) |
Diabetics, n (%) | 10 (38.4%) |
Hypertension, n (%) | 16 (62%) |
Hyperlipidemia, n (%) | 16 (62%) |
BB, n (%) | 26 (100%) |
MRA, n (%) | 26 (100%) |
Diuretics, n (%) | 26 (100%) |
Sinus Rythm, n (%) | 17 (65%) |
Atrial Fibrilation, n (%) | 4 (15%) |
ICD, n (%) | 6 (23%) |
CRT-D, n (%) | 8 (31%) |
LNEF (%) | 29.5 ± 1.0 |
LVESVi (ml/m2) | 38.6 ± 8.7 |